Head-to-head comparisons of medication uses, side effects, warnings, and more.
Tyenne (tocilizumab or tocilizumab-aazg) is a biologic medication and a biosimilar to Actemra (tocilizumab). It helps lower inflammation in certain autoimmune conditions like rheumatoid arthritis and juvenile idiopathic arthritis. It's also FDA approved to treat other conditions, including giant cell arteritis and COVID-19. Tyenne (tocilizumab) is given as an injection either under the skin or into a vein, depending on your condition. Common side effects include upper respiratory infections, headache, and injection‑site reactions.
Actemra (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist. It treats several inflammatory conditions in children and adults, including rheumatoid arthritis. It works by blocking IL-6, a chemical released by the immune system that causes inflammation and fever. Actemra (tocilizumab) is given as an injection (either through the veins or under the skin), typically weekly or every few weeks, depending on the condition you're taking it treat. Side effects include a higher risk of infections and headache.
^*The side effects listed above were reported in clinical trials where IV Tyenne (tocilizumab) was used to treat rheumatoid arthritis.^
Note: The side effects you experience might differ depending on why you're taking Actemra (tocilizumab) and whether you're receive it IV or SC.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.